Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-19

Clinical Trial Update: OctavaPink for Women With Dense Breast After Negative Mammography

View source ↗

Summary

Clinical trial update on OctavaPink for women with dense breast tissue after a negative mammogram; the current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OctavaPink

Snippet

Sponsor: Eventus Diagnostics Ltd | Conditions: Breast Cancer | Status: UNKNOWN